Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Meet the Next Resolution in Medicine -- Polaris Biology Releases Starion™, the next-generation mass cytometer
2021-10-23 15:05
Technological supremacy reigns in Chengdu
2021-10-22 21:14
2021 Bio-enzyme Application Explorer Summit held in Chengdu
2021-10-22 14:23
Specialised Therapeutics Enters into a New Supply and Distribution Agreement with Incyte to Launch Two New Cancer Therapies, Tafasitamab and Pemigatinib, in Australia, New Zealand and Singapore
2021-10-22 09:00
Aero HygenX Partners with Ethiopian Airlines for Deployment of Autonomous UV-C Disinfecting Solution
2021-10-21 21:57
Antengene Enters into a Research Collaboration & License Option Agreement with LegoChem Biosciences for New Antibody-Drug Conjugate Candidates
2021-10-21 16:00
Luoxin Pharmaceutical signs licensing agreement with Austria-based Marinomed Biotech AG for Budesolv® Budesonide Nasal Spray
2021-10-21 15:58
IND Application for Phase III Clinical Study of Anti-HER2 Bispecific Antibody KN026 was Officially Accepted by CDE
2021-10-21 10:31
Singapore-based Biosyngen receives 500 million yuan in investment
2021-10-21 09:30
GenFleet Announces First Patient Dosed in Phase Ib/II Trial of TGF-β R1 Inhibitor in Combination with PD-1 Inhibitor in Global Multi-center Research
2021-10-21 08:05
EVERSANA and Intouch Group join forces, adding the premiere digital-first agency network to the market leader in next generation commercialization
2021-10-20 22:34
BioVaxys Files US Patent Application for Pan-Sarbecovirus Vaccine
2021-10-20 21:24
Creatus Biosciences Inc. acquires the exclusive option to IP Assets from Stora Enso to Commercialize Xylitol Bioproduction from Biomass
2021-10-20 21:00
HistoIndex and Galecto to Collaborate on Galecto's Phase 2a MYLOX-1 Clinical Trial to Advance Myelofibrosis Assessment with AI-based Stain-free Digital Pathology
2021-10-20 18:00
Bridge Biotherapeutics Announces Initiation of the Phase I Clinical Trial for BBT-401 in China
2021-10-20 07:00
Alterity Therapeutics Announces Expanded ATH434 Phase 2 Clinical Development Program
2021-10-20 05:08
Insilico Medicine Appoints Business Leader, Michelle Chen, as Chief Business Officer
2021-10-19 23:30
Excelra Announces Addition of Sudip Nandy to its Board of Directors
2021-10-19 21:00
Moët Hennessy Breaks New Ground For Innovation: The Robert-Jean De Vogüé Research Center
2021-10-19 21:00
PharmAbcine Announces Patent Grant in Australia for Its Anti-VISTA Antibody
2021-10-19 20:00
1
203
204
205
206
207
440